|
Ultrasis PLC - Comparative Business Analysis Snapshot
Business Description
Ultrasis PLC(Ultrasis). The Group's principal activity is providing interactive healthcare products and services dedicated to the improvement of health, well being and personal performance. It focuses on drug-free computerised solutions that, based on the integration of advanced multimedia software, and knowledge in health and psychology help people tackle stress and a full spectrum of chronic conditions. It combines cognitive behavioral therapy, biofeedback and multimedia into self-help solutions, which help people measurably, reduce the symptoms of chronic conditions such as insomnia, depression, anxiety, stress or irritable bowel syndrome. The Group's flagship products, Beating the Blues is a computerised cognitive behavioural therapy programme for depression and anxiety that integrates psychological therapies with advanced multimedia software. The Group's other brands are Drink & Drug Wise, Relief Series and Calm Workplace.
Competitor Analysis
This analysis compares Ultrasis PLC with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
